How A Leading Chinese Biopharmaceutical Company Modernized Clinical Operations With Medidata CTMS And eTMF

As biopharmaceutical companies expand into multinational development, offline document management and disconnected point solutions quickly become a liability. One clinical-stage sponsor with a growing global pipeline found that manual, spreadsheet-based tracking couldn't keep pace with the traceability, consistency, and inspection-readiness that regulators worldwide now expect. Fragmented systems made it difficult to maintain ALCOA+ compliant records and left teams reacting to issues rather than catching them early.

By moving to an integrated, data-centric clinical trial management and document archiving system, the sponsor replaced manual tracking with centralized dashboards, automated document workflows, and real-time visibility across studies, all within a two-month global implementation. The result was a scalable foundation supporting consistent compliance across regions and faster, more informed decision-making. For sponsors managing an increasingly complex, multinational trial portfolio, disconnected tools and offline processes are no longer sustainable. Organizations facing similar scalability and compliance pressures should evaluate whether their current infrastructure can truly support real-time oversight, audit readiness, and long-term pipeline growth.